Company News

Industry News

Company News

Industry News

01

2025-03

Good News! Another Stem Cell Clinical Research Project Has Been Approved by the National Health Commission

Regenerative medicine technologies, exemplified by stem cell technology, represent the “third medical revolution” following pharmacological and surgical therapies. Stem cells possess the remarkable ability to differentiate into and form any type of tissue in vivo, as well as to self-renew and generate additional stem cells, making them a key frontier area of international medical research in recent years.

2025-03-01

Good News! Another Stem Cell Clinical Research Project Has Been Approved by the National Health Commission

01

2025-03

AI-Assisted Precise and Rapid Diagnosis of “Heart Conditions”

In recent years, Chinese enterprises have actively invested in research on the application of AI-powered medical imaging software in the field of cardiovascular diseases, resulting in the approval and launch of several products, primarily focused on niche areas such as coronary CT angiography and auxiliary analysis of electrocardiograms.

2025-03-01

AI-Assisted Precise and Rapid Diagnosis of “Heart Conditions”

01

2025-03

The drive for domestic substitution of high-end medical imaging equipment is unstoppable.

Medical imaging technology uses physical methods to acquire biological information, enabling the visualization of health status and serving as a core technology that drives the advancement of clinical disease early warning, diagnosis, and treatment.

2025-03-01

The drive for domestic substitution of high-end medical imaging equipment is unstoppable.

02

2023-03

Expanded authorization for batch release of biological products accelerates product market access.

To enhance the efficiency of batch release for biological products (vaccines), the National Medical Products Administration has decided, on the basis of a thorough risk assessment, to progressively expand the scope of provincial drug regulatory authorities’ testing and inspection institutions authorized to carry out batch release for biological products (vaccines), as well as the range of product types covered.

2023-03-02

Expanded authorization for batch release of biological products accelerates product market access.
< 1...10111213 >

Sorry，当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry，The current column has no content!

You can view other columns or return Home